Indee Labs

Scalable delivery of gene therapy.

Brief

Immunotherapies are the most promising development for cancer, in particular those based on personalising treatments using the patient’s cells.

Indee Labs has developed a scalable process using a microfluidic chip that inserts genetic therapies into human cells to help deliver cures to cancer and other diseases.

Investment

December 2017. Seed. Lead Partner: Mike Nicholls

Co-Investors

Founders Fund, Social Capital, Y-Combinator

Website

Go